Radiolabeled amino acids: basic aspects and clinical applications in oncology

PL Jager, W Vaalburg, J Pruim… - Journal of nuclear …, 2001 - Soc Nuclear Med
As the applications of metabolic imaging are expanding, radiolabeled amino acids may
gain increased clinical interest. This review first describes the basic aspects of amino acid …

The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis

E Bastiaannet, H Groen, PL Jager, DCP Cobben… - Cancer treatment …, 2004 - Elsevier
Background: Sarcomas represent a significant diagnostic and therapeutic challenge that
requires techniques to provide better assessment of the disease than provided by traditional …

[18F]FLT-PET in oncology: current status and opportunities

…, AJH Suurmeijer, DCP Cobben, PL Jager… - European journal of …, 2004 - Springer
In recent years, [ 18 F]-fluoro-3′-deoxy-3′-L-fluorothymidine ([ 18 F]FLT) has been
developed as a proliferation tracer. Imaging and measurement of proliferation with PET could …

Biodistribution of 89Zr‐trastuzumab and PET Imaging of HER2‐Positive Lesions in Patients With Metastatic Breast Cancer

…, JG Kosterink, AH Brouwers, PL Jager… - Clinical …, 2010 - Wiley Online Library
We performed a feasibility study to determine the optimal dosage and time of administration
of the monoclonal antibody zirconium‐89 ( 89 Zr)‐trastuzumab to enable positron emission …

[PDF][PDF] Indium-111–labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer

…, DJ van Veldhuisen, DT Sleijfer, PL Jager… - Journal of clinical …, 2006 - Citeseer
Purpose The cardiac and antineoplastic effects of trastuzumab may be related to specific
uptake of trastuzumab in myocardium and tumor tissue, respectively. We evaluated whether …

Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model

…, W Vaalburg, EFJ de Vries, PL Jager… - Journal of Nuclear …, 2004 - Soc Nuclear Med
… Matrigel was included to avoid migration of tumor cells to sites other than the place of
injection. Ten days later, 0.1 mL of turpentine was intramuscularly injected into the thigh of the left …

Esophageal Cancer: CT, Endoscopic US, and FDG PET for Assessment of Response to Neoadjuvant Therapy—Systematic Review1

…, OS Hoekstra, J Stoker, P Fockens, PL Jager… - Radiology, 2005 - pubs.rsna.org
PURPOSE: To compare diagnostic accuracy of computed tomography (CT), endoscopic
ultrasonography (US), and fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography …

Preclinical characterisation of 111In‐DTPA‐trastuzumab

…, AJH Suurmeijer, S de Jong, PL Jager… - British journal of …, 2004 - Wiley Online Library
Trastuzumab (Herceptin®) is a recombinant humanised IgG1 monoclonal antibody against
the human epidermal growth factor receptor 2 (HER2), used for metastatic breast cancer …

Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study

…, ANA van der Horst-Schrivers, PL Jager - The lancet …, 2006 - thelancet.com
… Dr Pieter L Jager, MD Pieter L JagerPL Jager participated in the design of the study,
patient recruitment, data analysis, interpretation of PET data, and writing of the report. …

[PDF][PDF] Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission …

…, K Vanghillewe, AH Brouwers, PL Jager… - Journal of clinical …, 2008 - researchgate.net
Jager, and Elisabeth GE de Vries … Jager, Elisabeth GE de Vries Manuscript writing: Klaas
P. Koopmans, Oliver C. Neels, Ido P. … Neels OC, Jager PL, Koopmans KP, et al: Development …